is it illegal to compound semaglutide Compounded "semaglutide" not FDA-approved New Novo Nordisk initiatives support

But simply joining two drugs together, without any tailoring to the patient, could lead to legal trouble, Brunner explains

Plaintiffs in these actions allege that manufacturers, primarily Novo Nordisk and Eli Lilly, failed to adequately warn prescribers and consumers about the risk of NAION and sudden vision loss associated with GLP1 drugs

That matters for adherence because people who see results early tend to stay on treatment longer

Wang W et al

Potential Side Effects and Risks The most commonly reported side effects in retatrutide clinical trials were gastrointestinal (GI) issues, similar to those seen with other GLP-1 receptor agonists